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Renal failure in children with hepatic 
failure undergoing liver transplantation 
Over a 3V2 year period, 133 children with hepatic failure underwent orthotopic 
liver transplantation (OLT) at our center. Renal failure (creatinine clearance 
<20 ml/min/1.73 m2) was present in 19 (14.3%) of these children. In seven of the 
19 children, renal failure was present before OLT, and in the other 12 after OLT. 
The causes of renal failure included hepatorenal syndrome in seven, postis-
chemic acute tubular necrosis in five, severe prerenal azotemia In five, and 
cyclosporine nephrotoxicity in two. Eight other patients died of renal failure 
while awaiting emergency transplantation. Of the total of 31 deaths among 133 
children who underwent OLT, nine occurred in the 19 patients with renal failure. 
Thus patients wllh OLT and renal failure had a significantly higher mortality than 
other patients with transplants (P <0.025). Dialysis was not associated with 
Improved survival. The majority of deaths in patients with renal failure were 
related to severe hemorrhage, thromboembolic events, and systemic fungal 
Infections. Our experience suggests that renal failure is common in children 
with hepatic failure and Is associated with reduced patient survival after OlT. (J 
PEDIATR 1986;108:393-398) 
Demetrius Ellis, M.D., Ellis D. Avner, M.D., and Thomas E. Starzl, M.D. 
From the Division of Pediatric Nephrology, Children's Hospital of Pittsburgh, and the Depart-
ment of Surgery, Presbyterian-University Hospital. University of Pittsburgh School of Medicine 
METHODS Refinements in surgical technique and the introduction of 
cyclosporine immunosuppression have greatly improved 
survival of children undergoing orthotopic liver transplan-
tation. l .s Over the past 31h years, 173 liver transplants have 
been performed in 133 pediatric patients. Referral of this 
large number of patients to our center for OLT has 
provided a unique opportunity to study the late complica-
tions associated with severe liver failure in childhood. 
Specifically, we have found a high incidence of renal 
failure, which complicates the pre- and perioperative 
management of these patients and which may contribute to 
their mortality. In this report, we describe the occurrence 
of renal failure in children with hepatic failure undergoing 
OL T and highlight the influence of renal failure on patient 
survival. 
Between June 1981 and December 1984, OLT was 
performed in 133 children at the Children's Hospital of 
Pittsburgh. Retrospective review of the clinical course in 
these patients was done to determine (1) the incidence and 
causes of renal failure, defined as GFR ::s20 mljmin/1.73 
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m2; and (2) the influence of renal failure and of dialysis on 
patient survival. We also examined the records of all 294 
children with severe liver failure referred to our center for 
pretransplant evaluation, to determine the prevalence of 
renal failure in this patient population. Only specific 
clinical aspects of this larger group of patients that pertain 
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Table I. Selected clinical features in 133 children 
undergoing orthotopic liver transplantation 
Age (yr) 
Mean ± SD 
Range 
Sex ratio (MjF) 
Allografts received (n = 173) 
Single 
Two or more 
Follow-up (mo) 
Mean ± SD 
Range 
One-year actuarial survival (%) 
Overall survival 
6.1 ± 4.7 
0.7 to 18.0 
I: 1.I 
98 (74%) 
35 (26%) 
12.5 ± 11.8 
I to 42 
7);5 
102 of 133 (76.7%) 
to the persistence or development of renal failure after 
OL T are discussed. 
In our study, the endogenous creatinine clearance was 
calculated from the mean of at least three serum creatinine 
values by the method of Schwartz et al.6 The fractional 
excretion of sodium and its interpretation were determined 
by previously described methods.7,8 
The clinical diagnosis of hepatorenal syndrome was 
established in patients with renal failure in the presence of 
severe hepatic failure by the absence of exposure to 
nephrotoxic medications, a normal urinary sediment, the 
presence of FENa + < 1.0%, and a progressive and propor-
tional rise in BUN and serum creatinine levels despite 
adequate blood volume expansion and blood pressure 
support through administration of blood, plasma, salt-poor 
albumin, and fluids.9• 12 In contrast to patients with HRS, 
those with post ischemic acute tubular necrosis were identi-
fied by an abrupt decrease in urine output; abnormal 
urinary findings consisting of microhematuria, proteinuria, 
and granular or tubular casts; FEN, + 2:2%; and a progres-
sive rise in BUN and serum creatinine and potassium 
concentrations following a readily identifiable hypoxic-
ischemic insult. In patients with pre renal azotemia, like 
those with HRS, results of urinalysis were normal and 
FENa+ <1.0%. However, unlike most patients with HRS, 
the BUN to serum creatinine ratio was 2:20, and a prompt 
rise in central venous pressure and improved urine output 
and renal function followed circulatory volume expansion. 
Patients with cyclosporine toxicity were differentiated 
from other patients with renal failure by an indolent 
decrease in renal function despite normal results of urinal-
ysis in the presence of blood trough cyclosporine levels 
>500 ngjml (HPLC). Such patients were further identi-
fied by prompt renal functional recovery after appropriate 
reduction in cyclosporine dosage to maintain trough blood 
levels of 100 to 200 ngj ml. 
Statistical analyses were done only in patients who had 
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Table II. Frequency of renal failure in children referred 
for liver transplantation 
n % 
Frequency of renal failure (GFR ::520 ml/min/1.73 m') 
Among all patients evaluated for 22 of 294 7.5 
possible OL T 
At time of admission for OL T 
In patients with transplants 
Renal failure before OL T 
Renal failure after OL T 
15 of 141 
190f133 
7 of 19 
12 of 19 
10.6 
14.3 
transplants. A standard t test was used to compare renal 
function studies between dialyzed and nondialyzed 
patients with renal failure. 1l The influence of renal failure 
on survival among patients undergoing OL T was analyzed 
by the chi-square method with a Yates correction,'] and 
the influence of dialysis on survival among patients with 
OL T and renal failure was assessed by the Fisher exact 
probability test. 1l 
RESULTS 
Selected clinical characteristics of the entire transplant 
popUlation are shown in Table I. Although a wide spec-
trum of disorders accounted for the liver failure, biliary 
hypoplasia or atresia and metabolic disorders were the 
principal hepatic diagnoses in 59% of these patients. The 
diagnosis of liver failure was based on the presence of 
marked increases in the plasma concentration of bilirubin 
and hepatic transaminase and ammonia values, whereas 
plasma albumin and clotting factors were frequently 
reduced. The majority of patients had jaundice, variable 
degrees of ascites, edema, muscle wasting, epistaxis, or 
gastrointestinal hemorrhage associated with portal hyper-
tension and disturbances in hemostasis, and hepatic 
encephalopathy. Other symptoms included anorexia and 
intermittent vomiting or diarrhea. Hypotension, often 
aggravated by orthostasis, was common, particularly in 
patients with ascites, even in the absence of overt gastroin-
testinal tract hemorrhage, abdominal paracentesis, condi-
tions leading to dehydration, or diuretic agents used to 
limit the rate of edema formation. During a 12.5 ± 11.8 
month (mean ± SO) follow-up period, the I-year actuari-
al patient survival in this population was 71.5%, and the 
overall survival at the time of this analysis was 76.7% (102 
of 133 patients). A complete report describing the preop-
erative, intraoperative, and postoperative care of this entire 
population is in preparation; thus we focus here specifically 
on the renal complications of OLT. 
Among 294 patients referred for initial medical screen-
ing to determine their suitability for eventual OL T, 7.5% 
(22 of 294) had renal failure (Table 11). However, of the 
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Table III. Clinical and corresponding nephropathologic diagnoses in 19 children with renal failure 
after liver transplantation 
Hepatorenal syndrome (n = 7) 
Postischemic acute renal failure (n = 5) 
Prerenal azotemia (n = 5) 
Cyclosporine nephrotoxicity (n = 2) 
Total (n = 19) 
Survival 
after OLl 
4 
o 
4 
2 
10 
141 patients who were subsequently admitted for OLT, 
10.6% (15 of 141) had renal failure. Of these 15 patients, 
eight died of complications before a transplant could be 
performed. Thus, seven of the patients who actually 
received transplants had established renal failure at the 
time of OLT, and an additional 12 patients developed renal 
failure after OLT. Therefore, in the 133 patients who 
actually recieved liver replacement, the incidence of renal 
failure was 14.3% (19 of 133). The clinical and histopath-
ologic findings in these 19 patients are shown in Table 
III. 
In all patients with renal failure, urine output was <400 
ml/m2/day, BUN 126 ± 53 mg/dl, and creatinine level 
5.5 ± 3.3 mg/dl (mean ± SD). Dialysis (hemodialysis in 
eight and peritoneal dialysis in two) was utilized in 10 of 
these 19 patients. The main indications for dialysis were 
mixed hepatic/uremic encephalopathy, symptomatic fluid 
overload, electrolyte imbalance, and uremic pericarditis. 
Specific aspects of the dialytic therapy in these children 
will be described in a subsequent report. The mean BUN 
concentration in dialyzed patients was not significantly 
higher than that in nondialyzed patients (147 vs 104 
mg/dl), but the GFR was significantly lower in patients 
receiving dialysis (17.5 vs 13.0 ml/min/ l.73 m2; P 
<0.05). 
Comparison of survival in the 19 patients with renal 
failure with that in 114 patients with no renal failure 
(Table IV) showed significantly lower survival in the 
patients with renal failure complicating OL T (P <0.025). 
Survival was similar whether or not the patient received 
dialysis. In addition, dialysis was not associated with 
decreased survival when all patients with OL T were 
considered (Fisher exact probability test, P = 0.1). Among 
patients with renal failure following OL T, the highest 
survival rate occurred in patients with prerenal azotemia, 
followed by those patients with cyclosporine nephrotoxicity 
or HRS. None of the five patients with post ischemic acute 
Autopsy Renal histopathologic findings 
3 
5 
9 
Enlarged, pale and edematous 
kidneys with normal architecture 
Acute tubular necrosis. four; A TN. 
papillary necrosis. and multiple 
fungal abscesses, one 
Preserved kidney size and normal 
architecture 
Table IV. Effect of renal failure and of dialysis on 
survival in children undergoing liver transplantation 
Patient survival 
In patients with kidney 
failure (n = 19) 
In patients without kidney 
failure (n = 114) 
n % 
10 52.6 
92 80.7 
Effect of dialysis on survival in patients with kidney 
failure 
Survival in dialyzed 
patients (n = 10) 
Survival in nondialyzed 
patients (n = 9) 
5 
5 
50.0 
55.6 
p 
<0.025 
NS 
Effect of dialysis on survival independent of renal failure 
Survival in dialyzed 5 50.0 
patients (n = 10) 
Survival in nondialyzed 
patients (n = 123) 
NS. not significant. 
97 78.9 
NS 
renal failure survived (Table III). Causes of death in the 
nine patients with renal failure after OLT included hemor-
rhage and infarction of the allograft in three, combined 
hemorrhage/infarction plus fungal infection in three, and 
rejection of the liver and hemorrhage in three. 
As shown in Table III, the clinical diagnoses were 
confirmed by renal histopathology in all nine patients with 
renal failure who died. At autopsy, the kidneys of patients 
who died with the clinical diagnosis of HRS were pale and 
markedly enlarged. Kidney weight and size were well 
above 100% for age in all three of these patients. There was 
jaundice of the renal parenchyma, and the tubUles contain-
ed occasional bilirubin casts. The glomeruli appeared 
enlarged. Apart from minimal interstitial edema, no other 
abnormalities were noted. The renal findings were similar 
in one other patient who died of prerenal azotemia, except 
for a smaller kidney size and weight than in patients with 
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HRS. In patients with acute tubular necrosis typical 
tubular findings included dilation of the tubular lumen, 
degeneration or regeneration of the tubular epithelial cells, 
and absence of any significant interstitial lymphocyte 
infiltrates. One patient with postischemic ATN also had 
extensive papillary necrosis and multiple abscesses with 
Aspergillus and Candida organisms throughout the renal 
parenchyma. Two other patients had a minimal number of 
Candida organisms in the renal tubules or in glomeruli, 
without any clinical or microbiologic evidence to suggest 
systemic candidiasis. 
DISCUSSION 
Our data demonstrate that renal failure is an important 
complication in children with hepatic failure. Renal failure 
was present or developed in 14.3% of patients undergoing 
OL T. The incidence of renal failure (i.e., number of 
patients with renal failure/total number of cases of liver 
failure leading to consideration of OL T) was 7.5%, where-
as the incidence of renal failure just before OL Twas 
10.6%. This increase in the incidence of renal failure 
reflected the further deterioration in hepatic function and 
general medical condition of the patients during the period 
between their previous evaluation and the time of actual 
transplantation. These figures provide only an estimate of 
the true incidence of renal failure in these patients, because 
our popula~ion is highly skewed by referral patterns and 
the availability of resources. Future prospective multicen-
ter studies are necessary to determine the true incidence of 
renal failure in patients with hepatic failure being consid-
ered for OL T. 
At our center, 4.1 % (I2 of 294) of the patients evaluated 
for transplantation and 5.3% (seven of 133) of patients 
undergoing transplantation had HRS. This represents the 
largest pediatric experience with HRS reported to date. 14-16 
Although the clinical picture of this syndrome is somewhat 
indistinct and its pathogenesis is incompletely understood, 
the combination of clinical and laboratory findings used to 
define HRS in this study meet several criteria for its 
diagnosis.9-1 2. 17. 18 Renal failure secondary to HRS resolved 
in four other patients after successful OL T, as previously 
reported in adults. 19 In these patients, in whom dialysis was 
required before OLT in all four and after OLT in three, 
renal function returned to normal levels 2 to 4 weeks after 
transplantation. Among the three patients with the clinical 
diagnosis of HRS who died after OLT, the relatively minor 
renal histopathologic findings were confirmatory.2o Causes 
of death in these three patients were systemic candidiasis 
and aspergillosis, air embolism, and massive necrosis of the 
allograft, respectively. Hence, persistent hepatic dysfunc-
tion or sepsis after OL T may have prevented renal func-
tional recovery in these patients. 
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The development of severe postoperative A TN and 
subsequent death in five patients was directly related to 
perioperative complications. The preexistence of HRS did 
not appear to predispose to the development of ATN, 
because it developed in none of the seven patients with 
HRS after OL T. Severe graft dysfunction, sepsis, and 
massive hemorrhage and hypotension combined to produce 
renal and systemic ischemia, which led to death in these 
patients. Thus, multisystem failure and not renal failure 
per se was directly responsible for patient deaths in this 
setting. 
The single patient who died of prerenal azotemia after 
OL T developed systemic candidiasis, septic phlebitis, and 
gastrointestinal tract hemorrhage several days after a third 
OLT, which functioned well. In this patient, few abscesses 
containing Candida organisms were found within the renal 
parenchyma. These findings were considered to represent 
late histopathologic changes, because the initial urinalysis 
results, FENa+, and clinical circumstances were compatible 
with prerenal azotemia secondary to low cardiac output. 
Mild and moderate cyclosporine nephrotoxicity is com-
mon in patients undergoing OL T,21 no doubt caused by the 
high doses of cyclosporine utilized, as reflected in high 
blood concentrations of this drug. However, severe 
nephrotoxicity developed in only two of our patients. In 
one, renal function improved only after temporary discon-
tinuation of cyclosporine and substitution of azathioprine; 
in the other, renal function improved after cyclosporine 
dosage adjustment. Hepatic function remains good in both 
patients. 
Survival in our patients with renal failure after OLT was 
significantly lower than in patients who did not have severe 
renal dysfunction (P <0.025). Systemic infection and 
hemorrhagic disorders, along with the severity of the 
underlying primary disorder or level of surgical success, 
greatly influence survival in patients with acute renal 
failure following trauma or major surgery.22-25 Dialysis has 
been reported to improve survival in such patients by 
improving recovery from bacterial infections and by 
decreasing the risks associated with hemorrhage from 
gastritis and gastrointestinal tract ulcers or from the 
cardiopulmonary consequences of fluid overload and elec-
trolyte disturbances.24. 26. 27 Death in most of our patients 
with combined liver and renal failure resulted from such 
causes as bleeding from varices, thromboembolic events, 
systemic fungal infections, and chemical disturbances 
resulting from severe hepatic failure. Hence it is not 
surprising that dialysis, although effective in controlling 
fluid and biochemical abnormalities, failed to improve 
survival in our patients. In at least one patient who died of 
severe gastrointestinal tract hemorrhage while undergoing 
hemodialysis with low doses of heparin, the dialysis proce-
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dure may have directly contributed to death. Thus our 
experience suggests that dialytic therapy may be helpful in 
the life support of patients with HRS awaiting OL T, but it 
provides little or no benefit in the patient in whom A TN is 
included in multisystem failure after OLT. 
The method we used to calculate GFR in our patients 
relies on the assumption that height and muscle mass are 
proportional.6 Inasmuch as muscle mass is reduced in most 
children with chronic liver failure, this method likely 
overestimates true GFR. Hence we believe that the renal 
failure in our patients was more severe than gauged by the 
calculated GFR. Despite significant differences in GFR 
between dialyzed and nondialyzed patients with OL T and 
renal failure, there was no difference in the survival rate of 
these two groups. This suggests that mortality was influ-
enced more by the development of renal failure and 
associated morbidity in other organs than by complications 
arising from the dialysis procedure. 
Although it is difficult to determine how renal failure 
affects survival in patients with severe liver failure or after 
OL T, there is little doubt that medical management 
becomes much more complicated in the presence of severe 
renal dysfunction. It is imperative that measures be taken 
to reduce the occurrence of renal failure in such patients, 
particularly because dialysis does not appear to decrease 
mortality in this setting. In patients with severe liver 
failure, it is mandatory that medical measures be taken to 
avoid hypovolemia or electrolyte imbalance, to decrease 
the risk of functional renal failure or HRS.9, 10, 14·18 If there 
is doubt about the adequacy of circulatory volume, diuretic 
agents and paracentesis should be discontinued and a trial 
of blood, plasma, or colloid infusion should be instituted, 
with central venous pressure or pulmonary arterial wedge 
pressure monitoring. Such therapy may be helpful in 
excluding prerenal azotemia in a patient in whom acute 
oliguria develops, with elevation in BUN and serum 
creatinine concentrations. However, repeated and exces-
sive attempts at blood volume expansion should be avoided 
in the absence of clinical response, because volume over-
load and acute pulmonary edema may supervene. In some 
patients, hypotension and increased susceptibility to acute 
renal failure may be related to factors other than simple 
circulatory inadequacy.2" For example, bile acids can 
produce vasodilation by blunting the effect of vasoactive 
agents, thereby reducing total peripheral resistance and 
decreasing ventricular afterload while simultaneously 
increasing renal sympathetic vasoconstriction and conse-
quently reducing renal blood flow and GFR. 
Periodic urinalysis and monitoring of renal function by 
regular monitoring of BUN, serum creatinine, and electro-
lytes are essential in patients with severe liver failure, 
particularly in those with ascites or in those receiving large 
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doses of diuretic agents. When renal failure supervenes, a 
low-protein, high-carbohydrate diet, aggressive treatment 
of infections, and gastrointestinal tract purging to limit 
urea and ammonia production are often helpful in decreas-
ing encephalopathic symptoms. Whenever possible, hepa-
totoxic and nephrotoxic medications should be avoided, 
drug dosages should be modified, and drug blood levels 
should be monitored. Guidelines are available for drug 
usage in such a setting.29. 30 
Our experience suggests that renal failure is common in 
children with hepatic failure and is associated with reduced 
patient survival after liver transplantation. Dialysis in 
patients with hepatic failure is hazardous and not effective 
in reducing overall mortality. Dialysis therefore should be 
considered mainly in patients with acute, reversible 
obstructive jaundice or in others in whom there is hope of 
reversing the hepatobiliary disorder by surgical procedures 
or by OLT.31 
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